The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?

Author: Chabbert-Buffet Nathalie  

Publisher: Informa Healthcare

ISSN: 1473-0782

Source: The European Journal of Contraception and Reproductive Health Care, Vol.18, Iss.2, 2013-04, pp. : 75-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract